BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hou C, Yin F, Wang S, Zhao A, Li Y, Liu Y. Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents. IDR 2022;Volume 15:1561-71. [DOI: 10.2147/idr.s357473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Bačić A, Milivojević V, Petković I, Kekić D, Gajić I, Medić Brkić B, Popadić D, Milosavljević T, Rajilić-stojanović M. In Search for Reasons behind Helicobacter pylori Eradication Failure–Assessment of the Antibiotics Resistance Rate and Co-Existence of Helicobacter pylori with Candida Species. JoF 2023;9:328. [DOI: 10.3390/jof9030328] [Reference Citation Analysis]
2 Boyanova L, Hadzhiyski P, Gergova R, Markovska R. Evolution of Helicobacter pylori Resistance to Antibiotics: A Topic of Increasing Concern. Antibiotics (Basel) 2023;12. [PMID: 36830243 DOI: 10.3390/antibiotics12020332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Qiao Y, Ma Y, Tong Y, Liu W, Wang S, Zheng Y, Men C, Yu J, Pan J, Wan D, Yin Y, Zhao X, Xi R, Meng M. Phototherapy and Mechanism Exploration of Biofilm and Multidrug-Resistant Helicobacter pylori by Bacteria-Targeted NIR Photosensitizer. Small 2023;19:e2205248. [PMID: 36417577 DOI: 10.1002/smll.202205248] [Reference Citation Analysis]
4 Krzyżek P, Puca V, Grande R. Editorial: Helicobacter pylori and its mechanisms of antibiotic survival. Front Cell Infect Microbiol 2023;13:1164227. [PMID: 36909728 DOI: 10.3389/fcimb.2023.1164227] [Reference Citation Analysis]
5 Chitas R, Nunes C, Reis S, Parreira P, Martins MCL. How Charge, Size and Protein Corona Modulate the Specific Activity of Nanostructured Lipid Carriers (NLC) against Helicobacter pylori. Pharmaceutics 2022;14. [PMID: 36559239 DOI: 10.3390/pharmaceutics14122745] [Reference Citation Analysis]
6 Wang J, Xie J, Liu Y, Zeng R, Xie Y. Global trends of Helicobacter pylori biofilm research in the past two decades: A bibliometric study (Preprint).. [DOI: 10.2196/preprints.44576] [Reference Citation Analysis]
7 Argueta EA, Ho JJC, Elfanagely Y, D'Agata E, Moss SF. Clinical Implication of Drug Resistance for H. pylori Management. Antibiotics (Basel) 2022;11. [PMID: 36551341 DOI: 10.3390/antibiotics11121684] [Reference Citation Analysis]
8 Jia X, Huang Q, Lin M, Chu Y, Shi Z, Zhang X, Ye H. Revealing the novel effect of Jinghua Weikang capsule against the antibiotic resistance of Helicobacter pylori. Front Microbiol 2022;13:962354. [DOI: 10.3389/fmicb.2022.962354] [Reference Citation Analysis]
9 Pan L, Yao Y, Zheng H, Yan S, Chen S. Inhibitory Effects and Mechanism of Action of Elsinochrome A on Candida albicans and Its Biofilm. JoF 2022;8:841. [DOI: 10.3390/jof8080841] [Reference Citation Analysis]
10 Zou Y, Chen X, Sun Y, Li P, Xu M, Fang P, Zhang S, Yuan G, Deng X, Hu H. Antibiotics-free nanoparticles eradicate Helicobacter pylori biofilms and intracellular bacteria. J Control Release 2022;348:370-85. [PMID: 35662575 DOI: 10.1016/j.jconrel.2022.05.044] [Reference Citation Analysis]